BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 35847480)

  • 1. Prevalence, parameters, and pathogenic mechanisms for splice-altering acceptor variants that disrupt the AG exclusion zone.
    Bryen SJ; Yuen M; Joshi H; Dawes R; Zhang K; Lu JK; Jones KJ; Liang C; Wong WK; Peduto AJ; Waddell LB; Evesson FJ; Cooper ST
    HGG Adv; 2022 Oct; 3(4):100125. PubMed ID: 35847480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome-wide detection of human intronic AG-gain variants located between splicing branchpoints and canonical splice acceptor sites.
    Zhang P; Chaldebas M; Ogishi M; Al Qureshah F; Ponsin K; Feng Y; Rinchai D; Milisavljevic B; Han JE; Moncada-Vélez M; Keles S; Schröder B; Stenson PD; Cooper DN; Cobat A; Boisson B; Zhang Q; Boisson-Dupuis S; Abel L; Casanova JL
    Proc Natl Acad Sci U S A; 2023 Nov; 120(46):e2314225120. PubMed ID: 37931111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AG-exclusion zone revisited: Lessons to learn from 91 intronic NF1 3' splice site mutations outside the canonical AG-dinucleotides.
    Wimmer K; Schamschula E; Wernstedt A; Traunfellner P; Amberger A; Zschocke J; Kroisel P; Chen Y; Callens T; Messiaen L
    Hum Mutat; 2020 Jun; 41(6):1145-1156. PubMed ID: 32126153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. All reported non-canonical splice site variants in GLA cause aberrant splicing.
    Okada E; Horinouchi T; Yamamura T; Aoto Y; Suzuki R; Ichikawa Y; Tanaka Y; Masuda C; Kitakado H; Kondo A; Sakakibara N; Ishiko S; Nagano C; Ishimori S; Usui J; Yamagata K; Matsuo M; Nozu K
    Clin Exp Nephrol; 2023 Sep; 27(9):737-746. PubMed ID: 37254000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined Bioinformatic and Splicing Analysis of Likely Benign Intronic and Synonymous Variants Reveals Evidence for Pathogenicity.
    Hirschi OR; Felker SA; Rednam SP; Vallance KL; Parsons DW; Roy A; Cooper GM; Plon SE
    medRxiv; 2023 Nov; ():. PubMed ID: 37961416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biased exon/intron distribution of cryptic and de novo 3' splice sites.
    Královicová J; Christensen MB; Vorechovský I
    Nucleic Acids Res; 2005; 33(15):4882-98. PubMed ID: 16141195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ParSE-seq: A Calibrated Multiplexed Assay to Facilitate the Clinical Classification of Putative Splice-altering Variants.
    O'Neill MJ; Yang T; Laudeman J; Calandranis M; Solus J; Roden DM; Glazer AM
    medRxiv; 2023 Sep; ():. PubMed ID: 37732247
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Rodríguez-Hidalgo M; de Bruijn SE; Corradi Z; Rodenburg K; Lara-López A; Valverde-Megías A; Ávila-Fernández A; Fernandez-Caballero L; Del Pozo-Valero M; Corominas J; Gilissen C; Irigoyen C; Cremers FPM; Ayuso C; Ruiz-Ederra J; Roosing S
    Front Genet; 2023; 14():1234032. PubMed ID: 37779911
    [No Abstract]   [Full Text] [Related]  

  • 9. Interpretable prioritization of splice variants in diagnostic next-generation sequencing.
    Danis D; Jacobsen JOB; Carmody LC; Gargano MA; McMurry JA; Hegde A; Haendel MA; Valentini G; Smedley D; Robinson PN
    Am J Hum Genet; 2021 Sep; 108(9):1564-1577. PubMed ID: 34289339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Splicing analysis of unclassified variants in COL2A1 and COL11A1 identifies deep intronic pathogenic mutations.
    Richards AJ; McNinch A; Whittaker J; Treacy B; Oakhill K; Poulson A; Snead MP
    Eur J Hum Genet; 2012 May; 20(5):552-8. PubMed ID: 22189268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A missense mutation in TTC8/BBS8 affecting mRNA splicing in patients with non-syndromic retinitis pigmentosa.
    Goyal S; Vanita V
    Mol Genet Genomics; 2022 Sep; 297(5):1439-1449. PubMed ID: 35939099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic Computational Identification of Variants That Activate Exonic and Intronic Cryptic Splice Sites.
    Lee M; Roos P; Sharma N; Atalar M; Evans TA; Pellicore MJ; Davis E; Lam AN; Stanley SE; Khalil SE; Solomon GM; Walker D; Raraigh KS; Vecchio-Pagan B; Armanios M; Cutting GR
    Am J Hum Genet; 2017 May; 100(5):751-765. PubMed ID: 28475858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-throughput analysis revealed mutations' diverging effects on
    Souček P; Réblová K; Kramárek M; Radová L; Grymová T; Hujová P; Kováčová T; Lexa M; Grodecká L; Freiberger T
    RNA Biol; 2019 Oct; 16(10):1364-1376. PubMed ID: 31213135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SpliceVault predicts the precise nature of variant-associated mis-splicing.
    Dawes R; Bournazos AM; Bryen SJ; Bommireddipalli S; Marchant RG; Joshi H; Cooper ST
    Nat Genet; 2023 Feb; 55(2):324-332. PubMed ID: 36747048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A class of human exons with predicted distant branch points revealed by analysis of AG dinucleotide exclusion zones.
    Gooding C; Clark F; Wollerton MC; Grellscheid SN; Groom H; Smith CW
    Genome Biol; 2006; 7(1):R1. PubMed ID: 16507133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Splicing analysis of rare/novel synonymous or intronic variants identified in ABCB11 heterozygotes presenting as progressive intrahepatic cholestasis with low γ-glutamyltransferase.
    Wang NL; Qiu YL; Guan WC; Li G; Lu Y; Zhang MH; Luan WS; Wang JS
    Hepatol Res; 2018 Jun; 48(7):574-584. PubMed ID: 29316097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of Noncanonical Splice Variants to
    Patel PN; Ito K; Willcox JAL; Haghighi A; Jang MY; Gorham JM; DePalma SR; Lam L; McDonough B; Johnson R; Lakdawala NK; Roberts A; Barton PJR; Cook SA; Fatkin D; Seidman CE; Seidman JG
    Circ Genom Precis Med; 2021 Oct; 14(5):e003389. PubMed ID: 34461741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combining genetic constraint with predictions of alternative splicing to prioritize deleterious splicing in rare disease studies.
    Cormier MJ; Pedersen BS; Bayrak-Toydemir P; Quinlan AR
    BMC Bioinformatics; 2022 Nov; 23(1):482. PubMed ID: 36376793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An intronic polypyrimidine-rich element downstream of the donor site modulates cystic fibrosis transmembrane conductance regulator exon 9 alternative splicing.
    Zuccato E; Buratti E; Stuani C; Baralle FE; Pagani F
    J Biol Chem; 2004 Apr; 279(17):16980-8. PubMed ID: 14966131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Eight Spliceogenic Variants in BRCA2 Exon 16 by Minigene Assays.
    Fraile-Bethencourt E; Valenzuela-Palomo A; Díez-Gómez B; Acedo A; Velasco EA
    Front Genet; 2018; 9():188. PubMed ID: 29881398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.